Ethics of clinical research and practice in India during the Covid-19 pandemic
| Autor: | Sahaj Rathi, Shriprakash Kalantri |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Vaccines
medicine.medical_specialty Evidence-Based Medicine Coronavirus disease 2019 (COVID-19) SARS-CoV-2 business.industry Cost-Benefit Analysis Public health MEDLINE COVID-19 India General Medicine Disease Evidence-based medicine Antiviral Agents Ethics Research Clinical research Ethics Clinical Novel virus Pandemic medicine Humans Intensive care medicine business Pandemics |
| Zdroj: | Indian Journal of Medical Ethics. :175-180 |
| ISSN: | 0975-5691 0974-8466 |
| DOI: | 10.20529/ijme.2020.080 |
| Popis: | Covid-19 has been one of the worst public health calamities faced by humankind in over a century. As of July 23, 2020, there have been 15,633,159 confirmed cases and 635,422 deaths reported, worldwide (1). We are six months into the pandemic, and yet we know little about the disease. The role of medicines is far from optimal, and vaccines are still under trials. Therefore, we have little to defend ourselves against this novel virus.brbr. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|